The IE2 regulatory protein of human cytomegalovirus induces expression of the human transforming growth factor β1 gene through an Egr-1 binding site

Journal of Virology

Volumn 70, Issue 10, 1996, Pages 7062-7070

  Yoo, Young Do ^a   Chiou, Chuang Jiun ^b   Choi, Kyeong Sook ^a,c   Yi, Youngsuk ^a   Michelson, Susan ^d   Kim, Sunyoung ^c   Hayward, Gary S ^b   Kim, Seong Jin ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Seoul National University   (South Korea)

^d INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

REGULATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; ZINC FINGER PROTEIN;

ARTICLE; ASTROCYTOMA CELL; BINDING SITE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; PRIORITY JOURNAL; PROTEIN DNA BINDING; REPORTER GENE;

EID: 0000465838     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.10.7062-7070.1996     Document Type: Article

References (68)

1. Baracchini, E., E. Glezer, K. Fish, R. M. Stenberg, J. A. Nelson, and P. Ghazal. 1992. An isoform variant of the cytomegalovirus immediate-early auto repressor functions as a transcriptional activator. Virology 188:518-529.
2. Benson, J. D., and E.-S. Huang. 1990. Human cytomegalovirus induces expression of cellular topoisomerase II. J. Virol. 64:9-15.
3. Birchenall-Roberts, M. C., F. W. Ruscetti, J. Kasper, H.-D. Lee, R. Friedman, A. G. Geiser, M. B. Sporn, A. B. Roberts, and S.-J. Kim. 1990. Transcriptional regulation of the transforming growth factor β1 promoter by v-src gene products is mediated through the AP-1 complex. Mol. Cell. Biol. 10: 4978-4983.
4. Cao, X., R. A. Koski, A. Gashler, M. McKiernan, C. F. Morris, R. Gaffney, R. V. Hay, and V. P. Sukhatme. 1990. Identification and characterization of the Egr-1 gene product, a DNA-binding protein induced by differentiation and growth signals. Mol. Cell. Biol. 10:1931-1939.
5. Caswell, R., C. Hagemeier, C.-J. Chiou, G. S. Hayward, T. Kouzarides, and J. Sinclair. 1993. The human cytomegalovirus 86K immediate early (IE)2 protein requires the basic region of the TATA-box binding protein (TBP) for binding and interacts with TBP and transcription factor TFIIB via regions of IE2 required for transcriptional regulation. J. Gen. Virol. 74:2691-2698.
6. Cayrol, C., and E. K. Flemington. 1995. Identification of cellular target genes of the Epstein-Barr virus transactivator Zta: activation of transforming growth factor β3 (TGF-β3) and TGF-β1. J. Virol. 69:4206-4212.
7. Chang, C.-P., C. L. Malone, and M. F. Stinski. 1989. A human cytomegalovirus early gene has three inducible promoters that are regulated differentially at various times after infection. J. Virol. 63:281-290.
8. Chang, Y.-N., D. L.-Y. Dong, G. S. Hayward, and S. D. Hayward. 1990. The Epstein-Barr virus Zta transactivator: a member of the bZIP family with unique DNA-binding specificity and a dimerization domain that lacks the characteristic heptad leucine zipper motif. J. Virol. 64:3358-3369.
9. Cherrington, J. M., E. L. Khoury, and E. S. Mocarski. 1991. Human cytomegalovirus IE2 negatively regulates gene expression via a short target sequence near the transcription start site. J. Virol. 65:887-896.
10. Chion, C.-J., and G. S. Hayward. Unpublished data.
11. Chiou, C.-J., J. Zong, I. Waheed, and G. S. Hayward. 1993. Identification and mapping of dimerization and DNA-binding domains in the C terminus of the IE2 regulatory protein of human cytomegalovirus. J. Virol. 67:6201-6214.
12. Colberg-Poley, A. M., D. Santomenna, P. A. Benfleld, and D. J. Tenny. 1992. Human cytomegalovirus US3 and UL36-38 immediate-early proteins regulate gene expression. J. Virol. 66:95-105.
13. + T cell clone, p. 139-144. In S. Michelson and S. A. Plotkin (ed.), Multidisciplinary approach to understanding cytomegalovirus disease. Excerpta Medica. Internation Congress series 1032. Elsevier Science Publishers, Amsterdam.
14. Davis, M. G., S. C. Kenney, J. Kammine, J. S. Pagano, and E.-S. Huang. 1987. Immediate-early gene region of human cytomegalovirus transactivates the promoter of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 84:8642-8646.
15. Depto, A. S., and R. M. Stenberg. 1992. Functional analysis of the true late human cytomegalovirus pp28 upstream promoter: cis-acting elements and viral transacting proteins necessary for promoter activation. J. Virol. 66: 3241-3246.
16. Dey, B., V. P. Sukhatme, M. B. Sporn, F. J. Rauscher III, A. B. Roberts, and S.-J. Kim. 1994. Repression of the transforming growth factor-β1 gene by the Wilm's tumor suppressor WT1 gene product. Mol. Endocrinol. 8:595-602.
17. Ewen, M. E., H. K. Sluss, L. L. Whitehouse, and D. M. Livingston. 1993. TGF-β inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell 74: 1009-1020.
18. Fan, K., Q. Ruan, L. Sensenbrenner, and B. Chen. 1992. Transforming growth factor-β1 bifunctionally regulates murine macrophage proliferation. Blood 79:1679-1685.
19. Frankel, S., R. Sohn, and L. Leinwand. 1991. The use of Sarkosyl in generating soluble protein after bacterial expression. Proc. Natl. Acad. Sci. USA 88:1192-1196.
20. Furnari, B. A., E. Poma, T. F. Kowalik, S.-M. Huong, and E.-S. Huang. 1993. Human cytomegalovirus immediate-early gene 2 protein interacts with itself and with several novel cellular proteins. J. Virol. 67:4981-4991.
21. Gashler, A. L., S. Swaminathan, and V. P. Sukhatme. 1993. A novel repression module, an extensive activation domain, and a bipartite nuclear localization signal defined in the immediate-early transcription factor Egr-1. Mol. Cell. Biol. 13:4556-4571.
22. Geiser, A. G., S.-J. Kim, A. B. Roberts, and M. B. Sporn. 1991. Characterization of the mouse transforming growth factor β1 promoter and activation by the Ha-ras oncogene. Mol. Cell. Biol. 11:84-92.
23. Gilardi, P., and M. Perricaudet. 1984. The E4 transcriptional unit of Ad2: far upstream sequences are required for its transactivation by E1A. Nucleic Acids Res. 12:7877-7888.
24. Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044-1051.
25. Hagemeier, C., R. Caswell, G. Hayhurst, J. Sinclair, and T. Kouzarides. 1994. Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein. EMBO J. 13:2897-2903.
26. Hagemeier, C., S. Walker, R. Caswell, T. Kouzarides, and J. Sinclair. 1992. The human cytomegalovirus 80-kilodalton hut not the 72-kilodalton immediate-early protein transactivates heterologous promoters in a TATA box-dependent mechanism and interacts directly with TFIID. J. Virol. 66:4452-4456.
27. Hermiston, T. W., C. L. Malone, P. R. Witte, and M. F. Stinski. 1987. Identification and characterization of the human cytomegalovirus immediate-early region 2 gene that stimulates gene expression from an inducible promoter. J. Virol. 61:3214-3221.
28. Kim. S.-J., P. Angel, R. Lafyatis, K. Hattori, K. Y. Kim, M. B. Sporn, M. Karin, and A. B. Roberts. 1990. Autoinduction of transforming growth factor β1 is mediated by the AP-1 complex. Mol. Cell. Biol. 10:1492-1497.
29. Kim, S.-J., B. R. Dey, B. B. Rudkin, K. Park, M. B. Sporn, and A. B. Roberts. 1994. Nerve growth factor induces transcription of transforming growth factor-β1 through a specific promoter element in PC12 cells. J. Biol. Chem. 269:3739-3744.
30. Kim, S.-J., A. Glick, M. B. Sporn, and A. B. Roberts. 1989. Characterization of the promoter region of the human transforming growth factor-β1 gene. J. Biol. Chem. 264:402-408.
31. Kim, S.-J., J. H. Kehrl, J. Burton, C. L. Tendler, K.-T. Jeang, D. Danielpour, C. Thevenin, K. Y. Kim, M. B. Sporn, and A. B. Roberts. 1990. Transactivation of the transforming growth factor β1 (TGF-β1) gene by human T-lymphotropic virus type 1 tax: a potential mechanism for the increased production of TGF-β1 in adult T-cell leukemia. J. Exp. Med. 172:121-129.
32. Kim, S.-J., H. D. Lee, P. D. Robbins, K. Busam, M. B. Sporn, and A. B. Roberts. 1991. Regulation of transforming growth factor-β1 gene expression by the product of the retinoblast-susceptibility gene. Proc. Natl. Acad. Sci. USA 88:3052-3056.
33. Kuchler, K. M., M. Sommer, J. T. Kaddnaga, and D. H. Spector. 1993. In vivo and in vitro analysis of transcriptional activation mediated by the human cytomegalovirus major immediate-early proteins. Mol. Cell. Biol. 13:1238-1250.
34. LaFemina, R. L., M. J. Pizzorno, J. D. Mosca, and G. S. Hayward. 1989. Expression of the acidic nuclear immediate-early protein (IE1) of human cytomegalovirus in stable cell lines and its preferential association with metaphase chromosome. Virology 172:584-600.
35. Lai, J.-S., and W. Herr. 1992. Ethidium bromide provides a simple tool for identifying genuine DNA-independent protein association. Proc. Natl. Acad. Sci. USA 89:6958-6962.
36. Lang, D., and T. Stamminger. 1993. The 86-kilodalton IE-2 protein of human cytomegalovirus is a sequence-specific DNA-binding protein that interacts directly with the negative autoregulatory response element located near the cap site of the IE-1/2 enhancer-promoter. J. Virol. 67:323-331.
37. Liu, B.,T. W. Hermiston, and M. F. Stinski. 1991. A cis-acting element in the major immediate-early (IE) promoter of human cytomegalovirus is required for negative regulation by IE2. J. Virol. 65:897-903.
38. Liu, B., and M. F. Stinski. 1992. Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements. J. Virol. 66:4434-4444.
39. Madden, S. L., D. M. Cook, J. F. Morris, A. Gashler, V. P. Sukhatme, and F. J. Rauscher III. 1991. Transcriptional repression mediated by the WT1 Wilm's tumor gene product. Science 253:1550-1553.
40. Maheswaran, S., S. Park, A. Bernard, J. F. Morris, F. J. Rauscher III, D. E. Hill, and D. A. Haber. 1993. Physical and functional interaction between WT1 and p53 proteins. Proc. Natl. Acad Sci. USA 90:5100-5104.
41. Malone, C. L., D. H. Vesole, and M. F. Stinski. 1990. Transactivation of human cytomegalovirus early promoter by gene products from the immediate-early gene IE2 and augmentation by IE1: mutational analysis of the viral proteins. J. Virol. 64:1498-1506.
42. Massagué, J. 1990. The transforming growth factor-beta family. Annu. Rev. Cell Biol. 6:597-641.
43. Michelson, S., J. Alcami, S.-J. Kim, D. Danielpour, L. Picard, C. Bessia, C. Paya, and J.-L. Virelizier. 1994. Human cytomegalovirus infection induces production of transforming growth factor β1. J. Virol. 68:5730-5737.
44. Nelson, B. J., P. Ralph, S. J. Green, and C. A. Nacy. 1991. Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-β1. J. Immunol. 146:1849-1857.
45. Nicholas, J. 1994. Nucleotide sequence analysis of a 21-kbp region of the genome of human herpesvirus-6 containing homologues of human cytomegalovirus major immediate-early and replication genes. Virology 204:738-750.
46. Obberghen-Schilling, E. V., N. S. Roche, K. C. Flanders, M. B. Sporn, and A. B. Roberts. 1988. Transforming growth factor β1 positively regulates its own expression in normal and transformed cells. J. Biol. Chem. 263:7741-7746.
47. Pietenpol, J. A., R. W. Stein, E. Moran, P. Yaciuk, R. Schlegel, R. M. Lyons, M. R. Pittelkow, K. Munger, P. M. Howley, and K. L. Moses. 1990. TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61:777-785.
48. Pizzorno, M. C., and G. S. Hayward. 1990. The IE2 gene products of human cytomegalovirus specifically down-regulate expression from the major immediate-early promoter through a target sequence located near the cap site. J. Virol. 64:6154-6165.
49. Pizzorno, M. C., M.-A. Mullen, Y.-N. Chang, and G. S. Hayward. 1991. The functionally active IE2 immediate-early regulatory protein of human cytomegalovirus is an 80-kilodalton polypeptide that contains two distinct activator domains and a duplicated nuclear localization signal. J. Virol. 65:3839-3852.
50. Pizzorno, M. C., P. O'Hare, L. Sha, R. L. LaFemina, and G. S. Hayward. 1988. trans activation and autoregulation of gene expression by the immediate-early region 2 gene products of human cytomegalovirus. J. Virol. 62: 1167-1179.
51. Pizzorno, M., I. Waheed, and G. S. Hayward. Unpublished data.
52. Roberts, A. B., and M. B. Sporn. 1990. The transforming growth factors-β, p. 419-472. In M. B. Sporn and A. B. Roberts (ed.). Handbook of experimental pharmacology, vol. 95/1. Peptide growth factors and their receptors. Springer-Verlag, New York.
53. Santomenna, L. D., and A. M. Colberg-Poley. 1990. Induction of cellular hsp70 expression by human cytomegalovirus. J. Virol. 64:2033-2040.
54. Sommer, M. H., A. L. Scully, and D. H. Spector. 1994. Transactivation by the human cytomegalovirus IE2 86-kilodalton protein requires a domain that binds to both the TATA box-binding protein and the retinoblastoma protein. J. Virol. 68:6223-6231.
55. Speir, E., R. Modali, E.-S. Huang, M. B. Leon, F. Shaw, T. Finkel, and S. E. Epstein. 1994. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265:391-394.
56. Sporn, M. B., and A. B. Roberts. 1990. TGF-β: problems and prospects. Cell Reg. 1:1-8.
57. Staprans, S. I., D. K. Rabert, and D. H. Spector. 1988. Identification of sequence requirements and trans-acting functions necessary for regulated expression of a human cytomegalovirus early gene. J. Virol. 62:3463-3473.
58. Stasiak, P. C., and E. S. Mocarski. 1992. Transactivation of the cytomegalovirus ICP36 gene promoter requires the alpha gene product TRS1 in addition to IE1 and IE2. J. Virol. 66:936-945.
59. Stenberg, R. M., A. S. Depto, J. Fortney, and J. A. Nelson. 1989. Regulated expression of early and late RNA and proteins from the human cytomegalovirus immediate-early gene region. J. Virol. 63:2699-2708.
60. Stenberg, R. M., J. Fortney, S. W. Barlow, B. P. Magrane, J. A. Nelson, and P. Ghazal. 1990. Promoter-specific trans activation and repression by human cytomegalovirus immediate-early proteins involves common and unique protein domains. J. Virol. 64:1556-1565.
61. Stenberg, R. M., P. R. Witte, and M. F. Stinski. 1985. Multiple spliced and unspliced transcripts from human cytomegalovirus immediate-early region 2 and evidence for a common initiation site within immediate-early region 1. J. Virol. 56:665-675.
62. Stinski, M. F., D. R. Thomsen, R. M. Stenberg, and L. C. Goldstein. 1983. Organization and expression of the immediate early genes of human cytomegalovirus. J. Virol. 46:1-14.
63. Strassmann, G. M., D. Cole, and W. Newman. 1988. Regulation of colony-stimulating factor-1 dependent macrophage precursor proliferation by type β transforming growth factor. J. Immunol. 140:2645-2651.
64. Sukhatme, V. P. 1990. Early transcriptional events in cell growth: the Egr family. J. Am. Soc. Nephrol. 1:859-866.
65. Tevethia, M. J., D. J. Spector, K. M. Leisure, and M. F. Stinski. 1987. Participation of two human cytomegalovirus immediate-early gene regions in transcriptional activation of adenovirus promoters. Virology 161:276-285.
66. Tsunawaki, S., M. B. Sporn, A. Ding, and C. Nathan. 1988. Deactivation of macrophages by transforming growth factor-β. Nature (London) 334:260-262.
67. Winkler, M., S. A. Rice, and T. Stamminger. 1994. UL49 of human cytomegalovirus, an open reading frame with homology to ICP27 of herpes simplex virus, encodes a transactivator of gene expression. J. Virol. 68:3943-3954.
68. Yoo, Y. D., H. Ueda, K. Park, K. C. Flanders, Y. I. Lee, G. Jay, and S.-J. Kim. 1996. Regulation of transforming growth factor-β1 expression by the hepatitis B-virus X transactivator: role in pathogenesis of HBV. J. Clin, Invest. 97:388-395.